This Article Full Text Full Text (PDF) All Versions of this Article: 110/12/1572    most recent 01.CIR.0000142047.28024.F2v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager patientINFORMation Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aguilar, D. Articles by Pfeffer, M. A. Search for Related Content PubMed PubMed Citation Articles by Aguilar, D. Articles by Pfeffer, M. A. Related Collections Acute myocardial infarction Type 2 diabetes

(Circulation. 2004;110:1572-1578.)
© 2004 American Heart Association, Inc.

Coronary Heart Disease

Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction

The Valsartan in Acute Myocardial Infarction (VALIANT) Trial

David Aguilar, MD; Scott D. Solomon, MD; Lars Køber, MD, DSc; Jean-Lucien Rouleau, MD; Hicham Skali, MD; John J.V. McMurray, MD; Gary S. Francis, MD; Marc Henis, MD; Christopher M. O’Connor, MD; Rafael Diaz, MD; Yuri N. Belenkov, MD, PhD; Sergei Varshavsky, MD; Jeffrey D. Leimberger, PhD; Eric J. Velazquez, MD; Robert M. Califf, MD; Marc A. Pfeffer, MD, PhD

From the University of Texas Health Science Center, Houston (D.A.); Brigham and Women’s Hospital, Boston, Mass (S.D.S., H.S., M.A.P.); Rigshospitalet, Copenhagen, Denmark (L.K.); Toronto Hospital, Toronto, Ontario, Canada (J.L.R.); University of Glasgow, Glasgow, United Kingdom (J.J.V.M.); The Cleveland Clinic Foundation, Cleveland, Ohio (G.S.F.); Medical Pharmaceutical Consultants, Randolph, NJ (M.H.); Duke Clinical Research Institute, Durham, NC (C.M.O., J.D.L., E.J.V, R.M.C.); Estudios Cardiologicos Latinoamerica, Santa Fe, Argentina (R.D.); Cardiology Research Institute, Moscow, Russia (Y.N.B.); and the CPR/Research Institute of Cardiology, St. Petersburg, Russia (S.V.).

Correspondence and reprint requests to Dr David Aguilar, Cardiovascular Division, University of Texas Health Science Center, 6431 Fannin, MSB 1.246, Houston, TX 77030. E-mail david.aguilar{at}uth.tmc.edu

Received January 29, 2004; revision received April 29, 2004; accepted May 18, 2004.

Background— A prior diagnosis of diabetes mellitus is associated with adverse outcomes after acute myocardial infarction (MI), but the risk associated with a new diagnosis of diabetes in this setting has not been well defined.

Methods and Results— We assessed the risk of death and major cardiovascular events associated with previously known and newly diagnosed diabetes by studying 14 703 patients with acute MI enrolled in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Patients were grouped by diabetic status: previously known diabetes (insulin use or diagnosis of diabetes before MI, n=3400, 23%); newly diagnosed diabetes (use of diabetic therapy or diabetes diagnosed at randomization [median 4.9 d after infarction], but no known diabetes at presentation, n=580, 4%); or no diabetes (n=10 719). Patients with newly diagnosed diabetes were younger and had fewer comorbid conditions than did patients with previously known diabetes. At 1 year after enrollment, patients with previously known and newly diagnosed diabetes had similarly increased adjusted risks of mortality (hazard ratio [HR] 1.43; 95% confidence interval [CI], 1.29 to 1.59 and HR, 1.50; 95% CI, 1.21 to 1.85, respectively) and cardiovascular events (HR, 1.37; 95% CI, 1.27 to 1.48 and HR, 1.34; 95% CI, 1.14 to 1.56).

Conclusions— Diabetes mellitus, whether newly diagnosed or previously known, is associated with poorer long-term outcomes after MI in high-risk patients. The poor prognosis of patients with newly diagnosed diabetes, despite having baseline characteristics similar to those of patients without diabetes, supports the idea that metabolic abnormalities contribute to their adverse outcomes.

Key Words: myocardial infarction • prognosis • diabetes mellitus • heart failure

Find additional patient-related information at:

Who is at Greater Risk for Heart Problems: Newly or Previously Diagnosed Patients With Diabetes?

This article has been cited by other articles:

				R Peter, A Cox, and M Evans Management of diabetes in cardiovascular patients Heart, March 1, 2008; 94(3): 369 - 375. [Full Text] [PDF]

				P. Ferdinandy, R. Schulz, and G. F. Baxter Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458. [Abstract] [Full Text] [PDF]

				M. Ishihara, I. Inoue, T. Kawagoe, Y. Shimatani, S. Kurisu, T. Hata, Y. Nakama, Y. Kijima, and E. Kagawa Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance? Eur. Heart J., October 2, 2006; 27(20): 2413 - 2419. [Abstract] [Full Text] [PDF]

				S. P. Marso, D. M. Safley, J. A. House, T. Tessendorf, K. J. Reid, and J. A. Spertus Suspected Acute Coronary Syndrome Patients With Diabetes and Normal Troponin-I Levels Are at Risk for Early and Late Death: Identification of a new high-risk acute coronary syndrome population Diabetes Care, August 1, 2006; 29(8): 1931 - 1932. [Full Text] [PDF]

				Z. T. Bloomgarden Cardiovascular Disease Diabetes Care, May 1, 2006; 29(5): 1160 - 1166. [Full Text] [PDF]

				D. S. Pinto, A. H. Skolnick, A. J. Kirtane, S. A. Murphy, H. V. Barron, R. P. Giugliano, C. P. Cannon, E. Braunwald, C. M. Gibson, and for the TIMI Study Group U-Shaped Relationship of Blood Glucose With Adverse Outcomes Among Patients With ST-Segment Elevation Myocardial Infarction J. Am. Coll. Cardiol., July 5, 2005; 46(1): 178 - 180. [Full Text] [PDF]

				Metabolic Link Between Diabetes and MI DOC News, January 1, 2005; 2(1): 22 - 22. [Full Text]

				Minerva BMJ, December 11, 2004; 329(7479): E335 - E335. [Full Text] [PDF]

				New Diabetes Linked with Poor Outcomes After MI Journal Watch (General), October 22, 2004; 2004(1022): 1 - 1. [Full Text]

				Minerva BMJ, October 2, 2004; 329(7469): 808 - 808. [Full Text] [PDF]